Article · 27 Dec 2024
Conference abstractPublished 15 Apr 2019
Biosimilars: Stability and quality considerations
Cairo University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Biosimilars are biological medicinal products that contain a version of the active substance of an already authorized original biological medicinal product (reference medicinal products). They shall demonstrate similarity to the reference medicinal products in terms of quality characteristics, biological activity, safety, efficacy and stability. Aim: The aim of this review is to discuss the relevant analytical reports that are concerned with the assessment of proposed products and reference products biosimilarity. Findings: The approval of biosimilars is a highly regulated, complicated and detailed process. The European Medicines Agency (EMA), The United States (US) Food and Drug Administration (FDA) guidance documents stipulate that biosimilar manufacturers shall perform a series of extensive similarity assessments to demonstrate biosimilarity to the reference product, and ultimately gain regulatory approval or licensure. Conclusion & Significance: Establishment of biosimilarity shall be based on the totality of evidence, through nonclinical and clinical studies. An increased awareness is needed to confirm that not only clinical studies can be used as an important tool in the development of biosimilars but also the analytical and stability evaluation is more sensitive in similarity assessment.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 10 Aug 2017
Considerations in biosimilars commercialization
Conference abstract · 10 Aug 2017
Some considerations about biosimilar safety
Conference abstract · 15 May 2017
CMC considerations for biosimilar drug development
Conference abstract · 27 Jun 2016
Analytical Assessment of Biosimilarity – Considerations in Study Design
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Nariman A El-Ragehy”
- BylineArticles whose byline prints “Maha A Hegazy”
- BylineArticles whose byline prints “G AbdEl Hamid”
- BylineArticles whose byline prints “Samia Ali Tawfik”

